Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration, Clinical Trial Study
< Back to Find a Trial

AHEAD 3-4/5 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

ID
NCT04468659
Condition Studied
Alzheimer's Disease
Phase
Phase III
Status
Open
Intervention
Lecanemab
Principal Investigator
Sponsor
Eisai Inc.
Contact Coordinator

Please go to https://www.aheadstudy.org/ or ClinicalTrials.gov for more information.